Want to see HK:6833 full AI Analyst Report?
Total Valuation
Sinco Pharmaceuticals Holdings Ltd. has a market cap or net worth of HK$284.60M. The enterprise value is HK$164.08.
Market CapHK$284.60M
Enterprise ValueHK$164.08
Share Statistics
Sinco Pharmaceuticals Holdings Ltd. has 2,032,890,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,032,890,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sinco Pharmaceuticals Holdings Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.92%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)5.92%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee8.11M
Profits Per Employee132.10K
Employee Count257
Asset Turnover1.13
Inventory Turnover7.17
Valuation Ratios
The current PE Ratio of Sinco Pharmaceuticals Holdings Ltd. is 8.1. Sinco Pharmaceuticals Holdings Ltd.’s PEG ratio is -0.62.
PE Ratio8.1
PS Ratio0.16
PB Ratio0.47
Price to Fair Value0.47
Price to FCF2.02
Price to Operating Cash Flow0.78
PEG Ratio-0.62
Income Statement
In the last 12 months, Sinco Pharmaceuticals Holdings Ltd. had revenue of 2.08B and earned 34.85M in profits. Earnings per share was 0.02.
Revenue2.08B
Gross Profit222.09M
Operating Income72.00M
Pretax Income48.26M
Net Income34.85M
EBITDA93.45M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 313.45M and capital expenditures -8.45M, giving a free cash flow of 305.00M billion.
Operating Cash Flow313.45M
Free Cash Flow305.00M
Free Cash Flow per Share0.15
Dividends & Yields
Sinco Pharmaceuticals Holdings Ltd. pays an annual dividend of HK$0.002, resulting in a dividend yield of 1.19%
Dividend Per ShareHK$0.002
Dividend Yield1.19%
Payout Ratio9.94%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-28.57%
50-Day Moving Average0.16
200-Day Moving Average0.17
Relative Strength Index (RSI)32.03
Average Volume (3m)115.20K
Important Dates
Sinco Pharmaceuticals Holdings Ltd. upcoming earnings date is Mar 31, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 31, 2027
Ex-Dividend Date―
Financial Position
Sinco Pharmaceuticals Holdings Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 16.42%
Current Ratio1.18
Quick Ratio0.95
Debt to Market Cap0.57
Net Debt to EBITDA-2.04
Interest Coverage Ratio2.18
Taxes
In the past 12 months, Sinco Pharmaceuticals Holdings Ltd. has paid 13.41M in taxes.
Income Tax13.41M
Effective Tax Rate0.28
Enterprise Valuation
Sinco Pharmaceuticals Holdings Ltd. EV to EBITDA ratio is 1.41, with an EV/FCF ratio of 0.83.
EV to Sales0.06
EV to EBITDA1.41
EV to Free Cash Flow0.83
EV to Operating Cash Flow0.78
Balance Sheet
Sinco Pharmaceuticals Holdings Ltd. has HK$369.41M in cash and marketable securities with HK$116.76M in debt, giving a net cash position of HK$252.65M billion.
Cash & Marketable SecuritiesHK$369.41M
Total DebtHK$116.76M
Net CashHK$252.65M
Net Cash Per ShareHK$0.12
Tangible Book Value Per ShareHK$0.28
Margins
Gross margin is 11.12%, with operating margin of 3.45%, and net profit margin of 1.67%.
Gross Margin11.12%
Operating Margin3.45%
Pretax Margin2.32%
Net Profit Margin1.67%
EBITDA Margin4.48%
EBIT Margin3.58%
Analyst Forecast
The average price target for Sinco Pharmaceuticals Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-20.04%
EPS Growth Forecast-25.66%